Jyong Biotech Ltd. (MENS)
NASDAQ: MENS · Real-Time Price · USD
2.020
-0.040 (-1.94%)
Oct 8, 2026, 11:52 AM EDT - Market open
Jyong Biotech Market Cap
Jyong Biotech has a market cap or net worth of $149.95 million as of October 8, 2026. It is the 22,650th most valuable company in the world and the 3,824th biggest in the United States. Its market cap has decreased by 96.46% in one year.
Market Cap
149.95M
Enterprise Value
167.33M
1-Year Change
-96.46%
Global Rank
Country Rank
#3,824 United States
Category
ChartMarket Cap Chart
Since June 17, 2025, Jyong Biotech's market cap has decreased from $777.46M to $149.95M, a decrease of -80.71%. That is a compound annual growth rate of -71.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 149.95M | -50.63% |
| Dec 31, 2025 | 303.76M | -60.93% |
| Jun 17, 2025 | 777.46M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NovaBridge Biosciences | 158.34M |
| Minerva Neurosciences | 157.33M |
| Anavex Life Sciences | 155.73M |
| Protara Therapeutics | 155.13M |
| Voyager Therapeutics | 154.04M |
| Codexis | 152.21M |
| Acumen Pharmaceuticals | 151.87M |
| Molecular Partners AG | 149.79M |